Assessing the post-treatment therapeutic effect of tongxie in irritable bowel syndrome: A randomized controlled trial

• Главные авторы: Yaoliang Lai (Автор), Xiao Liang (Автор), Heng Fan (Автор), Yujin Liu (Автор), Liang Zheng (Автор), Weimin Lu (Автор), Yuling Sun (Автор), Dawei Huang (Автор), Xingxing Liu (Автор), Lijian Zhang (Автор), Dongmei Zuo (Автор), Zhexing Shou (Автор), Qing Tang (Автор), Yuanyuan Wang (Автор), Zhen Li (Автор), Zhengyan Jiang (Автор), Shuo Zang (Автор), Huisuo Huang (Автор), Zongxiang Tang (Автор), Qian Li (Автор), Jun Xiao (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2022-09-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Diarrhea predominant irritable bowel syndrome (IBS) is a highly relapsing gastrointestinal disorder decreasing the quality of life. Existing studies indicated that the therapeutic effects maintained for a period of time after the treatments were discontinued (post-treatment therapeutic effects or PT...